This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Gemtuzumab ozogamicin is approved to treat:
- Acute myeloid leukemia that is CD33 positive.
- It is used in adults and children aged 2 or older whose disease has relapsed or is refractory (does not respond to treatment).
- It is used in adults with newly diagnosed disease.
Gemtuzumab ozogamicin is also being studied in the treatment of other types of cancer.
More About Gemtuzumab Ozogamicin
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia
Targeted Cancer Therapies
Clinical Trials Accepting Patients
Find Clinical Trials for Gemtuzumab Ozogamicin – Check for trials from TCH’s list of cancer clinical trials now accepting patients.